Back

The importance of cancer in the prediction of embolic and hemorrhagic risk in patients with atrial fibrillation

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Young Investigator Awards Session in Thrombosis Cardio-Oncology ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Ms Andrea Lizancos Castro

Germans Trias i Pujol Hospital, Barcelona (Spain)

2 More presentations in this session

Presentation thumbnail
Increased risk of long-term mortality following pulmonary embolism in Denmark, 2000-2020: A nationwide trend study.
Miss S. Fredslund Madsen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Predicting the presence of left atrial appendage thrombus with clinical features and transthoracic measurements using machine learning
Doctor K. Pieszko (Zielona Gora, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Awards Session in Thrombosis

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Cancer as independent risk factor for ischemic stroke in low-risk patients with atrial fibrillation: Swedish national cohort study
thumbnail
Congress Presentation
Use of direct oral anticoagulants in patients with atrial fibrillation and cancer: a subanalysis of the nationwide Italian START registry
thumbnail
Congress Presentation
Left atrial appendage occlusion in cancer patients with atrial fibrillation: closing the gap in stroke prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources